* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Indraprastha Medical's PEG Ratio or its related term are showing as below:
NSE:INDRAMEDCO'
s PEG Ratio Range Over the Past 10 Years
Min: 0.48 Med: 0.8 Max: 6.62
Current: 1.45
During the past 13 years, Indraprastha Medical's highest PEG Ratio was 6.62. The lowest was 0.48. And the median was 0.80.
NSE:INDRAMEDCO's PEG Ratio is ranked better than 56.25% of 224
companies
in the Healthcare Providers & Services industry
Industry Median: 1.58
vs NSE:INDRAMEDCO: 1.45
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Indraprastha Medical PEG Ratio Historical Data
The historical data trend for Indraprastha Medical's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Indraprastha Medical's PEG Ratio
For the Medical Care Facilities subindustry, Indraprastha Medical's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indraprastha Medical's PEG Ratio Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Indraprastha Medical's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Indraprastha Medical's PEG Ratio falls into.
Indraprastha Medical PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Indraprastha Medical (NSE:INDRAMEDCO) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Indraprastha Medical PEG Ratio Related Terms
Thank you for viewing the detailed overview of Indraprastha Medical's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Indraprastha Medical (NSE:INDRAMEDCO) Business Description
Indraprastha Medical Corp Ltd is an Indian company that operates in the healthcare business. It offers services in the field of anaesthesiology, pediatrics, bone marrow transplant, dental surgery, neonatology, dermatology, obesity, and metabolic surgery, orthopaedics, robotic surgery, spine surgery and in many other areas. The company also provides diagnosis, treatment, and management of various hormonal disorders; and inpatient and ambulatory care services. Geographically all the business activities of the group are carried out through the regions of India. It derives revenue from the provision of services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:INDRAMEDCO has been successfully added to your 